Arcadia Biosciences Announces Date of Fourth-Quarter and Ful

|Mar 11|magazine4 min read

DAVIS, Calif., March 11, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in sciencebased approaches to enhancing the quality and nutritional content of crops, today announced that it will release its 2019 fourth-quarter and full-year financial and business results after market close on March 25, 2020.

The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter results and the year's key strategic achievements. Interested participants can join the conference call using the following numbers:

U.S. Toll-Free Dial-In:

+1-844-243-4690 

International Dial-In:

+1-225-283-0138

Passcode:

8662765

A live webcast of the conference call will be available on the Investors section of Arcadia's website at www.arcadiabio.com. Following completion of the call, a recorded replay will be available on the company's investor website.

About Arcadia Biosciences, Inc.
Arcadia Biosciences (Nasdaq: RKDA) is a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients. The company's GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. Arcadia's agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. The company's new GoodHemp seed catalog delivers genetically superior hemp seeds, clones, transplants, flower and extracts, applying the company's proprietary crop innovation technology, ArcaTech, to an emerging crop.  For more information, visit www.arcadiabio.com. 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-announces-date-of-fourth-quarter-and-full-year-2019-financial-results-and-business-highlights-conference-call-301021320.html

SOURCE Arcadia Biosciences, Inc.